Literature DB >> 17578904

Comments on "Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel".

Stephen Fowler, Siân M Lennon, Gerhard Hoffmann, Craig R Rayner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17578904     DOI： 10.1124/jpet.106.118992

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  4 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Effect of oseltamivir on bleeding risk associated with warfarin therapy: a retrospective review.

Authors:  So-Hee Lee; Hye-Ryun Kang; Jae-Woo Jung; Jae-Woo Kwon; Kyoung-Sup Hong; Kyung-Sang Yu; Sang-Heon Cho
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

3.  Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.

Authors:  Sivasami Pulavendran; Jennifer M Rudd; Prasanthi Maram; Paul G Thomas; Ramachandran Akhilesh; Jerry R Malayer; Vincent T K Chow; Narasaraju Teluguakula
Journal:  Am J Respir Cell Mol Biol       Date:  2019-12       Impact factor: 6.914

4.  Inhibition of human carboxylesterases by ginsenosides: structure-activity relationships and inhibitory mechanism.

Authors:  Zhao-Hui Sun; Jing Chen; Yun-Qing Song; Tong-Yi Dou; Li-Wei Zou; Da-Cheng Hao; Hai-Bin Liu; Guang-Bo Ge; Ling Yang
Journal:  Chin Med       Date:  2019-12-16       Impact factor: 5.455
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.